Insider Trading News

Digital Arts EVP Jacob Schatz sells shares price $215,174

Jacob J. Schatz, Govt Vice President of World Affairs and Chief Authorized Officer at Digital Arts Inc . (NASDAQ:EA), has…

10 hours ago

Equitable Holdings’ government Nick Lane sells $1.29 million in inventory

Nick Lane, Head of Retirement, Wealth Administration & Safety Options at Equitable Holdings, Inc. (NYSE:EQH), just lately bought shares value…

11 hours ago

Worldwide Seaways CEO Lois Zabrocky sells $82,565 in inventory

Lois Ok. Zabrocky, President and CEO of Worldwide Seaways, Inc. (NYSE:INSW), just lately offered 2,000 shares of the corporate's widespread…

11 hours ago

JPMorgan Chase’s co-CEO CIB Petno sells $886,565 in frequent inventory

Douglas B. Petno, Co-CEO of the Company & Funding Financial institution at JPMorgan Chase & Co. (NYSE:JPM), lately offered a…

12 hours ago

JPMorgan Chase chief threat officer Ashley Bacon sells $1.81 million in inventory

Ashley Bacon, Chief Threat Officer at JPMorgan Chase & Co. (NYSE:JPM), lately bought 7,122 shares of the corporate's widespread inventory,…

13 hours ago

JPMorgan Chase’s basic counsel Stacey Friedman sells $838,778 in inventory

Stacey Friedman, Normal Counsel at JPMorgan Chase & Co. (NYSE:JPM), just lately executed a sale of firm inventory valued at…

14 hours ago

JPMorgan Chase CEO sells $1.34 million in inventory

Mary E. Erdoes, CEO of Asset & Wealth Administration at JPMorgan Chase & Co. (NYSE:JPM), just lately offered a portion…

15 hours ago

JPMorgan Chase & Co CEO CCB sells $1.08 million in inventory

NEW YORK—Lake Marianne, CEO of Client & Neighborhood Banking at JPMorgan Chase & Co (NYSE:JPM), lately bought shares of the…

16 hours ago

Summit Midstream CEO sells $113,730 in widespread inventory

HOUSTON—J. Heath Deneke, Chairman, President, and CEO of Summit Midstream Corp (NASDAQ:NYSE:SMC), lately bought shares of the corporate's widespread inventory,…

17 hours ago

Vyne therapeutics director Patrick Lepore buys $43,800 in inventory

Patrick G. LePore, a director at VYNE Therapeutics Inc. (NASDAQ:VYNE), not too long ago acquired 15,000 shares of the corporate's…

18 hours ago